Paul Chan: Hong Kong Continues to Support Cross-Border Elderly Care
Paul Chan, Secretary for Finance of the Hong Kong Special Administrative Region Government, delivered the government’s 2026–2027 fiscal year budget to the Legislative Council today (the 25th). He stated that the SAR Government has consistently provided support for cross-border elderly care. Starting this month, the “Guangdong Residential Care Service Scheme” has expanded to include two additional providers, bringing the total to 26 and covering nine mainland cities in the Greater Bay Area. At the end of last year, a two-year “pilot medical subsidy arrangement” was also launched, with a cap of RMB 10,000 per person per year for outpatient fees and RMB 30,000 for inpatient fees. In addition, the SAR Government will introduce new arrangements in the middle of the year, allowing elderly participants in the “Guangdong Scheme,” “Fujian Scheme,” and “Comprehensive Social Security Assistance (CSSA) Elderly Care Schemes for Guangdong and Fujian Provinces” to opt for the SAR Government to transfer funds directly into their designated mainland bank accounts. (Greater Bay Area Voice)
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
9
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading









